How Should the Impact of Different Presentations of Treatment Effects on Patient Choice Be Evaluated? A Pilot Randomized Trial (original) (raw)
The Effect of Alternative Summary Statistics for Communicating Risk Reduction on Decisions About Taking Statins: A Randomized Trial
Shaun Treweek
PLoS …, 2009
View PDFchevron_right
The Statin Choice decision aid in primary care: A randomized trial
Victor M Montori
Patient Education and Counseling, 2010
View PDFchevron_right
Observational data for comparative effectiveness research: An emulation of randomised trials of statins and primary prevention of coronary heart disease
Luis Rodríguez
Statistical Methods in Medical Research, 2013
View PDFchevron_right
Bias in Observational Studies of Prevalent Users: Lessons for Comparative Effectiveness Research From a Meta-Analysis of Statins
Mohammad Tavakkoli
American Journal of Epidemiology, 2012
View PDFchevron_right
“Clinician’s Use of the Statin Choice Decision Aid in Patients with Diabetes: a Videographic Study Nested in a Randomized Trial.”
Victor M Montori, Roberto Abadie
View PDFchevron_right
The effect of qualitative vs. quantitative presentation of probability estimates on patient decision-making: a randomized trial
Jennifer Biggs
Health Expectations, 2002
View PDFchevron_right
The Effect of How Outcomes Are Framed on Decisions about Whether to Take Antihypertensive Medication: A Randomized Trial
Doris Kristoffersen, Victor M Montori
PLoS ONE, 2010
View PDFchevron_right
Patients’ self-estimated likelihood of taking a statin as prescribed after different types of prognostic information
Stefan Agewall
Atherosclerosis, 2010
View PDFchevron_right
Factors Associated with Findings of Published Trials of Drug–Drug Comparisons: Why Some Statins Appear More Efficacious than Others
Lisa Bero
PLoS Medicine, 2007
View PDFchevron_right
Impact of effectiveness information format on patient choice of therapy and satisfaction with decisions about chronic disease medication: the "Influence of intervention Methodologies on Patient Choice of Therapy (IMPACT)" cluster-randomised trial in general practice
A. Edwards, Dorte Jarbøl
BMC Health Services Research, 2013
View PDFchevron_right
Communicating clinical trial outcomes: Effects of presentation method on physicians’ evaluations of new treatments
Jonathan Rolison
View PDFchevron_right
Communicating risk using absolute risk reduction or prolongation of life formats: cluster-randomised trial in general practice
Dorte Jarbøl
British Journal of General Practice, 2014
View PDFchevron_right
Iranian general populations' and health care providers' preferences for benefits and harms of statin therapy for primary prevention of cardiovascular disease
Hamid Reza Baradaran
BMC Medical Informatics and Decision Making
View PDFchevron_right
Benefit–risk assessment of HMG-CoA reductase inhibitors (statins): a discrete choice experiment
Korn Sornlertlumvanich
BMJ Open
View PDFchevron_right
How statistical deception created the appearance that statins are safe and effective in primary and secondary prevention of cardiovascular disease
Uffe Ravnskov
Expert review of clinical pharmacology, 2015
View PDFchevron_right
Should Statin Therapy Be Allocated on the Basis of Global Risk or on the Basis of Randomized Trial Evidence?
Steven Jones
The American Journal of Cardiology, 2010
View PDFchevron_right
Statistical issues in randomised controlled trials: a narrative synthesis
B. Egbewale
Asian Pacific Journal of Tropical Biomedicine, 2015
View PDFchevron_right
Use of Meta-analytic Results to Facilitate Shared Decision Making
Daniel Cher
Journal of the American Medical Informatics Association, 1999
View PDFchevron_right
Risk communication in clinical trials: A cognitive experiment and a survey
Cynthia Goh
BMC Medical Informatics and Decision Making, 2010
View PDFchevron_right
The Changing Face of Clinical Trials Evidence for Health Decision Making — Beyond Randomized, Controlled Trials
Maestría Ciencias Médicas
View PDFchevron_right
Study protocol for statin web-based investigation of side effects (StatinWISE): a series of randomised controlled N-of-1 trials comparing atorvastatin and placebo in UK primary care
Emily Herrett
BMJ open, 2017
View PDFchevron_right
Improved adherence to statin treatment and differences in results between men and women after pictorial risk communication—a sub-study of the VIPVIZA RCT
Ulf Näslund
European journal of clinical pharmacology, 2024
View PDFchevron_right
Providing additional information about the benefits of statins in a leaflet for patients with coronary heart disease: a qualitative study of the impact on attitudes and beliefs
Peter Knapp
BMJ open, 2016
View PDFchevron_right
Identifying patient preferences for communicating risk estimates: a descriptive pilot study
Nananda Col
BMC medical informatics and decision making, 2001
View PDFchevron_right
Guidance for a causal comparative effectiveness analysis emulating a target trial based on big real world evidence: when to start statin treatment
Felicitas Kuehne
Journal of Comparative Effectiveness Research, 2019
View PDFchevron_right
Patients Prefer Pictures to Numbers to Express Cardiovascular Benefit From Treatment
Sue Wells
The Annals of Family Medicine, 2008
View PDFchevron_right
Misperception among physicians and patients regarding the risks and benefits of statin treatment: the potential role of direct-to-consumer advertising
Phil Mendys
Journal of Clinical Lipidology, 2008
View PDFchevron_right